Fifth Third Bancorp Financials - Benzinga

SPY766.53+0.30%QQQ740.93+0.41%BTC/USD84,279.28+0.78%DIA512.82−0.01%GLD383.07+0.05%TLT78.07−0.21%

Fifth Third Bancorp

FITBNYSE

Trade with Public

Trade with Public

$50.84

-0.13-0.26%

Last update: Sep 30, 9:53 AM

Dividend: The dividend Ex-Date is today

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Dividends Compare Options Stock Report

Fifth Third Bancorp Financials

Fifth Third Bancorp (FITB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Fifth Third Stock Falls Despite Strong Earnings — Analysts See Comerica Merger Upside Ahead

Shares of FITB traded under pressure despite upbeat Q2 earnings. DA Davidson, RBC Capital analysts raised price target.

Priya Nigam

These Analysts Boost Their Forecasts On Fifth Third Bancorp Following Upbeat Q2 Results

Fifth Third Bancorp (FITB) reported 2Q earnings beat with $1.02 per share, beating analyst consensus of 95 cents. Revenue also beat expectations.

Avi Kapoor

What's Going On With the Drop in Fifth Third Stock

Fifth Third Bancorp (NASDAQ: FITB) shares are sliding on Friday despite posting second-quarter earnings beat.

Evette Mitkov

Earnings Scheduled For July 17, 2026

Companies Reporting Before The Bell • Travelers Companies (NYSE:TRV) is estimated to report quarterly earnings at $4.94 per share on revenue of $11.23 billion. • South Plains Financial (NASDAQ:SPFI) is projected to

Benzinga Insights

PRO
Fifth Third Bancorp Q2 Adj. EPS $1.02 Beats $0.95 Estimate, Sales $3.279B Beat $3.250B Estimate

Fifth Third Bancorp (NASDAQ:FITB) reported quarterly earnings of $1.02 per share which beat the analyst consensus estimate of $0.95 by 7.37 percent. This is a 13.33 percent increase over earnings of $0.90 per share from

Benzinga Newsdesk

Nasdaq Tumbles 1.5% Amid Selloff In Chip Stocks: Investor Sentiment Weakens, Greed Index Moves To ‘Fear’ Zone

Market sentiment declined as stocks fell, with tech stocks leading the way. UnitedHealth Group and Abbott Laboratories reported strong earnings.

Avi Kapoor

© 2026 Benzinga | All Rights Reserved